CTNNB1 and neoplasm: Analysis of triple mutants (PBCre4 Ctnnb1+/Δex3Ptenfl/fl; K-Ras+/G12V) revealed these three genetic alterations could synergize to drive aggressive tumor progression relative to double or single mutants via increased mTORC1 activity [189].